Soochow Securities: VV116 preparation and its industrial chain have a large market space Post date May 17, 2022 — 10:41 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 17, 2022 — 03:42 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 17, 2022 — 01:19 Post Lock Read More Fuxiang Pharmaceutical was criticized in the circular due to the issue of letter disclosure, and the performance will be expressed or re-introduced to investors' "reverie". Post date May 13, 2022 — 01:11 Post Lock Read More V View Financial Report Fuxiang Pharmaceutical was criticized for failing to clarify rumors in a timely manner – yqqlm Post date May 12, 2022 — 22:34 Post Lock Read More Fuxiang Pharmaceutical: The company holds a 3.9% stake in Lingkai Pharmaceutical and a 39.2% stake in Lingfu Pharmaceutical Research Institute Post date May 12, 2022 — 20:48 Post Lock Read More Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 17, 2022 — 03:42 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 17, 2022 — 01:19 Post Lock Read More Fuxiang Pharmaceutical was criticized in the circular due to the issue of letter disclosure, and the performance will be expressed or re-introduced to investors' "reverie". Post date May 13, 2022 — 01:11 Post Lock Read More V View Financial Report Fuxiang Pharmaceutical was criticized for failing to clarify rumors in a timely manner – yqqlm Post date May 12, 2022 — 22:34 Post Lock Read More Fuxiang Pharmaceutical: The company holds a 3.9% stake in Lingkai Pharmaceutical and a 39.2% stake in Lingfu Pharmaceutical Research Institute Post date May 12, 2022 — 20:48 Post Lock Read More Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 17, 2022 — 01:19 Post Lock Read More Fuxiang Pharmaceutical was criticized in the circular due to the issue of letter disclosure, and the performance will be expressed or re-introduced to investors' "reverie". Post date May 13, 2022 — 01:11 Post Lock Read More V View Financial Report Fuxiang Pharmaceutical was criticized for failing to clarify rumors in a timely manner – yqqlm Post date May 12, 2022 — 22:34 Post Lock Read More Fuxiang Pharmaceutical: The company holds a 3.9% stake in Lingkai Pharmaceutical and a 39.2% stake in Lingfu Pharmaceutical Research Institute Post date May 12, 2022 — 20:48 Post Lock Read More Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical was criticized in the circular due to the issue of letter disclosure, and the performance will be expressed or re-introduced to investors' "reverie". Post date May 13, 2022 — 01:11 Post Lock Read More V View Financial Report Fuxiang Pharmaceutical was criticized for failing to clarify rumors in a timely manner – yqqlm Post date May 12, 2022 — 22:34 Post Lock Read More Fuxiang Pharmaceutical: The company holds a 3.9% stake in Lingkai Pharmaceutical and a 39.2% stake in Lingfu Pharmaceutical Research Institute Post date May 12, 2022 — 20:48 Post Lock Read More Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
V View Financial Report Fuxiang Pharmaceutical was criticized for failing to clarify rumors in a timely manner – yqqlm Post date May 12, 2022 — 22:34 Post Lock Read More Fuxiang Pharmaceutical: The company holds a 3.9% stake in Lingkai Pharmaceutical and a 39.2% stake in Lingfu Pharmaceutical Research Institute Post date May 12, 2022 — 20:48 Post Lock Read More Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company holds a 3.9% stake in Lingkai Pharmaceutical and a 39.2% stake in Lingfu Pharmaceutical Research Institute Post date May 12, 2022 — 20:48 Post Lock Read More Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company's argatroban injection is listed on the Internet in accordance with the bidding and procurement policies of various provinces, and all work is in progress in an orderly manner Post date May 12, 2022 — 20:42 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company will have an annual output of 15,000 tons of VC, 3,000 tons of FEC products, 5,000 tons of methylphenyldichlorosilane, 2,500 tons of methylphenylcyclotrisiloxane and 1,000 tons of silazane and other special silicones Product capacity Post date May 12, 2022 — 20:41 Post Lock Read More Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company signed a contract for Paroved intermediates with Lingkai Pharmaceuticals Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company has not yet provided Junshi Bio with intermediates for the new crown Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company has entrusted an evaluation agency to evaluate the recoverable amount of the investment target Post date May 12, 2022 — 20:17 Post Lock Read More Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: At present, the company's cooperation projects with Lingfu and Lingkai are not affected Post date May 12, 2022 — 19:53 Post Lock Read More Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fuxiang Pharmaceutical: The company will have an annual production capacity of 15,000 tons of VC and 3,000 tons of FEC products Post date May 12, 2022 — 19:51 Post Lock Read More There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
There are 12 more annual report inquiry letters! Nearly 300 stocks in the two cities have been questioned, and it is difficult to reply to the extension of these stocks Post date May 12, 2022 — 12:21 Post Lock Read More 3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews Post date May 11, 2022 — 20:54 Post Lock Read More Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hongyuan Pharmaceutical's inventory has increased abnormally, and long-term illegal pollution discharge has been held accountable. The authenticity of the letter is questioned. Internet channel Rongyi Information Network Post date May 11, 2022 — 02:39 Post Lock Read More "Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
"Take down" the domestic oral medicine for the new crown! Just now, 30 billion pharmaceutical stocks have a strong daily limit! The concept of new crown medicine broke out collectively, and the strongest has 9 daily limit in 11 days! Stocks Financial World Post date May 9, 2022 — 23:58 Post Lock Read More The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan. Post date May 9, 2022 — 18:53 Post Lock Read More The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The concept of new crown treatment continues to be active Post date May 9, 2022 — 14:23 Post Lock Read More What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board Post date May 9, 2022 — 13:06 Post Lock Read More
Caishen.CoCaishen.Co